LDHA and ovarian neoplasm: ALDH positive SKOV-3 and Hey1 ovarian CSCs and primary ovarian tumor cells positive for ALDH and CD133 have enhanced resistance to therapies and exhibit enhanced tumor growth in vivo [105].